Development of a Novel 18 F-Labeled Probe for PET Imaging of Estrogen Receptor β
Journal of Medicinal Chemistry · 26.01.2023 · 66 (2) · 1210-1220
DOI: 10.1021/acs.jmedchem.2c00761 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 05.01.2023. Verfasst von Yujing Zhou und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Huashan Hospital, Fudan University, No. 12 Urumchi Middle Road, Jing'an District, Shanghai, 200040, China. Hauptthemen laut MEDLINE: Estrogen Receptor beta, Estradiol. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Estrogen receptor beta (ERβ) is an important ER subtype that plays crucial roles in many physiological and pathological disorders. Herein, we developed the probe [18F]PVBO for in vivo ERβ targeted PET imaging and obtained promising results. The nonradioactive PVBO showed a 12.5-fold stronger binding affinity to ERβ than to ERα in vitro. In vitro assays revealed the specific uptake of [18F]PVBO by DU145 cells. The uptake of [18F]PVBO by DU145 xenografts increased during the 120 min dynamic scanning, with a maximum uptake of 2.80 ± 0.30% ID/g. Based on time activity curves (TACs), the injection of [18F]PVBO with unlabeled PVBO or ERB-041 resulted in a significant signal reduction with the tumor/muscle (T/M) ratio
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Huashan Hospital, Fudan University, No. 12 Urumchi Middle Road, Jing'an District, Shanghai, 200040, China.
- State Key Laboratory of Drug Research, Molecular Imaging Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
- Department of Nuclear Medicine, Pudong Hospital, Fudan University, Shanghai, 201399, China.
- Department of Nuclear Medicine, Qilu Hospital, Shandong University, Jinan, Shandong Province, 250012, China.
- Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
- State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Wuhan, Hubei Province, 430062, China.
ORCID-Profile: Yujing Zhou, Xiaoqing Zhang, Weiliang Zhu, Zhijian Xu, Hao Chen, Zhen Cheng
Förderung
- Ministry of Science and Technology of the People's Republic of China
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Lingang Laboratory
- Pudong Hospital, Fudan University
Zitieren
APA
Zhou, Y., Lei, P., Han, J., Wang, Z., Ji, A., Wu, Y., Zheng, L., Zhang, X., Qu, C., Min, J., Zhu, W., Xu, Z., Liu, X., Chen, H., & Cheng, Z. (2023). Development of a Novel 18 F-Labeled Probe for PET Imaging of Estrogen Receptor β. Journal of Medicinal Chemistry, 66(2), 1210-1220. https://doi.org/10.1021/acs.jmedchem.2c00761
Vancouver
Zhou Y, Lei P, Han J, Wang Z, Ji A, Wu Y, et al. Development of a Novel 18 F-Labeled Probe for PET Imaging of Estrogen Receptor β. Journal of Medicinal Chemistry. 2023;66(2):1210-1220. doi:10.1021/acs.jmedchem.2c00761
BibTeX
@article{Zhou2023,
author = {Zhou, Yujing and Lei, Peng and Han, Jiaxin and Wang, Zhiming and Ji, Aiyan and Wu, Yuyang and Zheng, Lingling and Zhang, Xiaoqing and Qu, Chunrong and Min, Jian and Zhu, Weiliang and Xu, Zhijian and Liu, Xingdang and Chen, Hao and Cheng, Zhen},
title = {Development of a Novel 18 F-Labeled Probe for PET Imaging of Estrogen Receptor β},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {2},
pages = {1210--1220},
doi = {10.1021/acs.jmedchem.2c00761}
}
EUVIMED